Chair: Gerbrand vd Heden-van Noort (LUMC)
Rob Lammers (LEI): Iminosugar-based PROTACs for targeted protein degradation of non-lysosomal glucocerebrosidase (GBA2) and glucosylceramide synthase (GCS)
Nila van Overbeek (LEI): A Chemogenetic CRISPR Knock-out Screen Uncovers Synergy Between Ubiquitin Signalling and C16orf72/HAPSTR1 for S-phase Entry
Niels Keijzer (NKI): Mechanistic analysis of USP1 reveals exo-cleavage mechanism that regulates DNA Damage Tolerance